S&P 500   3,252.02 (-1.75%)
DOW   26,329.23 (-1.24%)
QQQ   267.97 (-3.05%)
AAPL   108.07 (-6.29%)
MSFT   200.65 (-1.99%)
FB   259.93 (-7.44%)
GOOGL   1,606.65 (+3.20%)
AMZN   3,026.84 (-5.74%)
TSLA   387.02 (-5.80%)
NVDA   496.09 (-4.77%)
BABA   304.74 (-2.50%)
CGC   18.67 (-0.59%)
GE   7.33 (-0.54%)
MU   49.88 (-1.19%)
AMD   74.71 (-4.24%)
T   26.80 (+0.15%)
F   7.66 (-3.04%)
ACB   4.04 (-1.22%)
GILD   57.80 (-1.25%)
NIO   30.64 (-4.22%)
NFLX   473.58 (-6.07%)
BA   142.92 (-3.62%)
DIS   119.80 (-1.43%)
S&P 500   3,252.02 (-1.75%)
DOW   26,329.23 (-1.24%)
QQQ   267.97 (-3.05%)
AAPL   108.07 (-6.29%)
MSFT   200.65 (-1.99%)
FB   259.93 (-7.44%)
GOOGL   1,606.65 (+3.20%)
AMZN   3,026.84 (-5.74%)
TSLA   387.02 (-5.80%)
NVDA   496.09 (-4.77%)
BABA   304.74 (-2.50%)
CGC   18.67 (-0.59%)
GE   7.33 (-0.54%)
MU   49.88 (-1.19%)
AMD   74.71 (-4.24%)
T   26.80 (+0.15%)
F   7.66 (-3.04%)
ACB   4.04 (-1.22%)
GILD   57.80 (-1.25%)
NIO   30.64 (-4.22%)
NFLX   473.58 (-6.07%)
BA   142.92 (-3.62%)
DIS   119.80 (-1.43%)
S&P 500   3,252.02 (-1.75%)
DOW   26,329.23 (-1.24%)
QQQ   267.97 (-3.05%)
AAPL   108.07 (-6.29%)
MSFT   200.65 (-1.99%)
FB   259.93 (-7.44%)
GOOGL   1,606.65 (+3.20%)
AMZN   3,026.84 (-5.74%)
TSLA   387.02 (-5.80%)
NVDA   496.09 (-4.77%)
BABA   304.74 (-2.50%)
CGC   18.67 (-0.59%)
GE   7.33 (-0.54%)
MU   49.88 (-1.19%)
AMD   74.71 (-4.24%)
T   26.80 (+0.15%)
F   7.66 (-3.04%)
ACB   4.04 (-1.22%)
GILD   57.80 (-1.25%)
NIO   30.64 (-4.22%)
NFLX   473.58 (-6.07%)
BA   142.92 (-3.62%)
DIS   119.80 (-1.43%)
S&P 500   3,252.02 (-1.75%)
DOW   26,329.23 (-1.24%)
QQQ   267.97 (-3.05%)
AAPL   108.07 (-6.29%)
MSFT   200.65 (-1.99%)
FB   259.93 (-7.44%)
GOOGL   1,606.65 (+3.20%)
AMZN   3,026.84 (-5.74%)
TSLA   387.02 (-5.80%)
NVDA   496.09 (-4.77%)
BABA   304.74 (-2.50%)
CGC   18.67 (-0.59%)
GE   7.33 (-0.54%)
MU   49.88 (-1.19%)
AMD   74.71 (-4.24%)
T   26.80 (+0.15%)
F   7.66 (-3.04%)
ACB   4.04 (-1.22%)
GILD   57.80 (-1.25%)
NIO   30.64 (-4.22%)
NFLX   473.58 (-6.07%)
BA   142.92 (-3.62%)
DIS   119.80 (-1.43%)
Log in
NASDAQ:IART

Integra LifeSciences Stock Forecast, Price & News

$43.60
+0.29 (+0.67 %)
(As of 10/30/2020 03:33 PM ET)
Add
Compare
Today's Range
$42.15
Now: $43.60
$43.73
50-Day Range
$43.33
MA: $47.17
$51.88
52-Week Range
$34.21
Now: $43.60
$63.23
Volume14,078 shs
Average Volume568,334 shs
Market Capitalization$3.67 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.02
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. It operates in two segments, Codman Specialty Surgical, and Orthopedics and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, hydrocephalus management systems, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it sells hardware products, such as bone and joint fixation, and joint replacement devices; and implants and instruments, which provide for the orthopedic reconstruction of bone in the hand, wrist, elbow, and shoulder, as well as the foot, ankle, and leg below the knee in the extremity bone and joint reconstruction procedures. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was founded in 1989 and is headquartered in Princeton, New Jersey.
Read More
Integra LifeSciences logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.2Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.72 out of 5 stars

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:IART
CUSIP45798520
Phone609-275-0500
Employees4,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.52 billion
Cash Flow$3.74 per share
Book Value$16.50 per share

Profitability

Net Income$50.20 million

Miscellaneous

Market Cap$3.67 billion
Next Earnings Date2/17/2021 (Estimated)
OptionableOptionable
$43.60
+0.29 (+0.67 %)
(As of 10/30/2020 03:33 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IART News and Ratings via Email

Sign-up to receive the latest news and ratings for IART and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Integra LifeSciences (NASDAQ:IART) Frequently Asked Questions

How has Integra LifeSciences' stock been impacted by COVID-19?

Integra LifeSciences' stock was trading at $46.08 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, IART stock has decreased by 5.6% and is now trading at $43.51.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Integra LifeSciences?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Integra LifeSciences in the last year. There are currently 1 sell rating, 6 hold ratings and 5 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Integra LifeSciences
.

When is Integra LifeSciences' next earnings date?

Integra LifeSciences is scheduled to release its next quarterly earnings announcement on Wednesday, February 17th 2021.
View our earnings forecast for Integra LifeSciences
.

How were Integra LifeSciences' earnings last quarter?

Integra LifeSciences Holdings Co. (NASDAQ:IART) posted its quarterly earnings results on Wednesday, October, 28th. The life sciences company reported $0.80 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $0.57 by $0.23. Integra LifeSciences had a positive return on equity of 13.64% and a negative net margin of 0.25%.
View Integra LifeSciences' earnings history
.

When did Integra LifeSciences' stock split? How did Integra LifeSciences' stock split work?

Integra LifeSciences shares split on Tuesday, January 3rd 2017. The 2-1 split was announced on Thursday, December 22nd 2016. The newly minted shares were issued to shareholders after the closing bell on Wednesday, December 21st 2016. An investor that had 100 shares of Integra LifeSciences stock prior to the split would have 200 shares after the split.

What guidance has Integra LifeSciences issued on next quarter's earnings?

Integra LifeSciences issued an update on its third quarter 2020 After-Hours earnings guidance on Tuesday, October, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $368-370 million, compared to the consensus revenue estimate of $340.39 million.

What price target have analysts set for IART?

12 analysts have issued twelve-month price targets for Integra LifeSciences' shares. Their forecasts range from $46.00 to $65.00. On average, they anticipate Integra LifeSciences' stock price to reach $55.92 in the next twelve months. This suggests a possible upside of 28.5% from the stock's current price.
View analysts' price targets for Integra LifeSciences
.

Are investors shorting Integra LifeSciences?

Integra LifeSciences saw a decrease in short interest in the month of October. As of October 15th, there was short interest totaling 3,590,000 shares, a decrease of 12.9% from the September 30th total of 4,120,000 shares. Based on an average daily volume of 456,800 shares, the days-to-cover ratio is presently 7.9 days. Currently, 5.0% of the shares of the company are short sold.
View Integra LifeSciences' Short Interest
.

Who are some of Integra LifeSciences' key competitors?

What other stocks do shareholders of Integra LifeSciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Integra LifeSciences investors own include The Boeing (BA), NVIDIA (NVDA), AbbVie (ABBV), Adobe (ADBE), Advanced Micro Devices (AMD), Gilead Sciences (GILD), Intel (INTC), Marvell Technology Group (MRVL), Alexion Pharmaceuticals (ALXN) and Abbott Laboratories (ABT).

Who are Integra LifeSciences' key executives?

Integra LifeSciences' management team includes the following people:
  • Mr. Peter J. Arduini, Pres, CEO & Director (Age 55, Pay $2.16M)
  • Ms. Carrie L. Anderson, Exec. VP & CFO (Age 51, Pay $705.93k)
  • Mr. Glenn G. Coleman, Exec. VP & COO (Age 52, Pay $1.08M)
  • Mr. Eric Ian Schwartz, Exec. VP, Chief Legal Officer & Sec. (Age 51, Pay $692.5k)
  • Mr. Robert T. Davis Jr., Exec. VP and Pres of Orthopedics & Tissue Technologies (Age 61, Pay $742.41k)
  • Dr. Richard E. Caruso, Founder and Chairman Emeritus (Age 77)
  • Mr. Jeffrey Mosebrook, Sr. VP, Principal Accounting Officer & Corp. Controller (Age 44)
  • Dr. Kenneth E. Burhop Ph.D., Corp. VP & Chief Scientific Officer (Age 66)
  • Mr. William Compton, Chief Information Officer & Sr. VP
  • Mr. Sravan K. Emany, Sr. VP of Strategy, Treasury & Investor Relations

What is Integra LifeSciences' stock symbol?

Integra LifeSciences trades on the NASDAQ under the ticker symbol "IART."

Who are Integra LifeSciences' major shareholders?

Integra LifeSciences' stock is owned by a number of retail and institutional investors. Top institutional investors include Tributary Capital Management LLC (0.61%), Assenagon Asset Management S.A. (0.11%), Retirement Systems of Alabama (0.11%), State of New Jersey Common Pension Fund D (0.07%), Envestnet Asset Management Inc. (0.06%) and Diversified Trust Co (0.03%). Company insiders that own Integra LifeSciences stock include Barbara B Hill, Christian S Schade, Daniel L Reuvers, Eric Schwartz, Glenn Coleman, John Mooradian, Kenneth Burhop, Lisa Evoli, Peter J Arduini, Raymond G Murphy, Rhonda Germany Ballintyn, Richard E Caruso, Stuart Essig and Tru St Partnership, LP.
View institutional ownership trends for Integra LifeSciences
.

Which institutional investors are selling Integra LifeSciences stock?

IART stock was sold by a variety of institutional investors in the last quarter, including Tributary Capital Management LLC, New Mexico Educational Retirement Board, Envestnet Asset Management Inc., New Mexico Educational Retirement Board, State of Alaska Department of Revenue, and AMG National Trust Bank. Company insiders that have sold Integra LifeSciences company stock in the last year include Eric Schwartz, Glenn Coleman, Lisa Evoli, Peter J Arduini, Richard E Caruso, Stuart Essig, and Tru St Partnership, LP.
View insider buying and selling activity for Integra LifeSciences
.

Which institutional investors are buying Integra LifeSciences stock?

IART stock was acquired by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Pacer Advisors Inc., WINTON GROUP Ltd, State of New Jersey Common Pension Fund D, Diversified Trust Co, Xponance Inc., Cardinal Capital Management, and Retirement Systems of Alabama. Company insiders that have bought Integra LifeSciences stock in the last two years include Barbara B Hill, and Rhonda Germany Ballintyn.
View insider buying and selling activity for Integra LifeSciences
.

How do I buy shares of Integra LifeSciences?

Shares of IART can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Integra LifeSciences' stock price today?

One share of IART stock can currently be purchased for approximately $43.51.

How big of a company is Integra LifeSciences?

Integra LifeSciences has a market capitalization of $3.67 billion and generates $1.52 billion in revenue each year. The life sciences company earns $50.20 million in net income (profit) each year or $2.74 on an earnings per share basis. Integra LifeSciences employs 4,000 workers across the globe.

What is Integra LifeSciences' official website?

The official website for Integra LifeSciences is www.integralife.com.

How can I contact Integra LifeSciences?

Integra LifeSciences' mailing address is 311 ENTERPRISE DRIVE, PLAINSBORO NJ, 08536. The life sciences company can be reached via phone at 609-275-0500 or via email at [email protected]

This page was last updated on 10/30/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.